Adam Roseman ARC China

A young leader in Los Angeles’ business community, Adam M. Roseman is the CEO and Founder of ARC China, Inc., an international strategic and advisory private equity firm focused on investing in and partnering with domestic Chinese companies that have high growth potential.  Though Roseman’s business ventures make him an international traveler for much of the year, his charitable endeavors allow him to focus efforts on building his home community through his involvement with the Cedars-Sinai Board of Governors.

Roseman’s position on the Board of Governors allows him and other community leaders to play an important role in overseeing many aspects of Cedars-Sinai’s Medical Center by providing “vital support to the hospital’s clinical programs, biomedical research, and community outreach.”  The world-renowned Medical Center lives up to its reputation of providing top-notch patient care and pioneering leading-edge research, thanks in part to the Board of Governors’ active participation in fund raising and leadership.

As a generous contributor to multiple research projects ranging from men’s health to orthopedics to oncology, Roseman is a strong advocate for the pioneering of new technologies in the medical field.  He has also been actively involved in the Sports Spectacular annual event to benefit the Cedars-Sinai Medical Genetics Institute and has served as a high-level sponsor in years past.

“I feel honored to have been chosen as a member of Cedars-Sinai’s prestigious Board of Governors.  Making tangible contributions to such a highly-respected organization like Cedars-Sinai is one of the best ways I can think of to invest in the health and wellbeing of our community’s present and future,”

said Roseman.

Adam Roseman is the founder and CEO of ARC China.

ARC China is a private equity company that focuses on investment and partnerships with domestic Chinese companies that exhibit high potential for growth. ARC China operates out of its offices in Chengdu, Shanghai, Los Angeles and New York.

ARC China’s twenty five member team focuses primarily on activities across various Chinese industries – specifically healthcare, clean-technology, resources and consumer industries.

ARC China is involved in a host of financial and business activities, managing a number of investment funds and maintaining relationships with various financial concerns across the globe who partner with ARC China, investing with ARC to provide resources to a variety of companies in China. ARC’s partners in these efforts include venture capital companies, private equity firms and private investors as well as other financial institutions.